{
  "approved_at_utc": null,
  "subreddit": "stocks",
  "selftext": "Running up huge on volume right now! Thoughts? \n\n&#x200B;\n\nResearchers awarded funding to expand Akebia drug trial\n\nUTHealth News says Researchers have received funding from the Department of Defense to expand the Phase II clinical trial of vadadustat, a drug being developed by Akebia that could help prevent acute respiratory distress syndrome in Covid-19 patients, at The University of Texas Health Science Center at Houston, UTHealth News' Amy Laukka reports. The award was given through the DOD's Peer Reviewed Medical Research Program as a COVID Clinical Trial Award, according to the report. Akebia recently completed its global Phase III clinical trial development for the treatment of anemia due to chronic kidney disease in patients on dialysis and not on dialysis.\n\n&#x200B;\n\nDOD funding helps expand study of investigational drug to prevent ARDS in COVID [https://www.eurekalert.org/pub\\_releases/2021-01/uoth-dfh011321.php](https://www.eurekalert.org/pub_releases/2021-01/uoth-dfh011321.php)\n\n\\------ \n\n## 39th Annual J.P. Morgan Healthcare Conference\n\n### January 13, 2021 at 2:50 PM EST\n\n### [https://ir.akebia.com/events/event-details/39th-annual-jp-morgan-healthcare-conference](https://ir.akebia.com/events/event-details/39th-annual-jp-morgan-healthcare-conference)",
  "author_fullname": "t2_13baya",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "$AKBA DOD Funding News Drop and JP Morgan presentation today @ 2:50PM EST",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/stocks",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": null,
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": true,
  "name": "t3_kwmolz",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.99,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 266,
  "total_awards_received": 0,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": null,
  "can_mod_post": false,
  "score": 266,
  "approved_by": null,
  "author_premium": false,
  "thumbnail": "",
  "edited": false,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {},
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1610591629,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.stocks",
  "allow_live_comments": true,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Running up huge on volume right now! Thoughts? </p>\n\n<p>&#x200B;</p>\n\n<p>Researchers awarded funding to expand Akebia drug trial</p>\n\n<p>UTHealth News says Researchers have received funding from the Department of Defense to expand the Phase II clinical trial of vadadustat, a drug being developed by Akebia that could help prevent acute respiratory distress syndrome in Covid-19 patients, at The University of Texas Health Science Center at Houston, UTHealth News&#39; Amy Laukka reports. The award was given through the DOD&#39;s Peer Reviewed Medical Research Program as a COVID Clinical Trial Award, according to the report. Akebia recently completed its global Phase III clinical trial development for the treatment of anemia due to chronic kidney disease in patients on dialysis and not on dialysis.</p>\n\n<p>&#x200B;</p>\n\n<p>DOD funding helps expand study of investigational drug to prevent ARDS in COVID <a href=\"https://www.eurekalert.org/pub_releases/2021-01/uoth-dfh011321.php\">https://www.eurekalert.org/pub_releases/2021-01/uoth-dfh011321.php</a></p>\n\n<p>------ </p>\n\n<h2>39th Annual J.P. Morgan Healthcare Conference</h2>\n\n<h3>January 13, 2021 at 2:50 PM EST</h3>\n\n<h3><a href=\"https://ir.akebia.com/events/event-details/39th-annual-jp-morgan-healthcare-conference\">https://ir.akebia.com/events/event-details/39th-annual-jp-morgan-healthcare-conference</a></h3>\n</div><!-- SC_ON -->",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qjfk",
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "",
  "id": "kwmolz",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "returntrip1",
  "discussion_type": null,
  "num_comments": 30,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/stocks/comments/kwmolz/akba_dod_funding_news_drop_and_jp_morgan/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/stocks/comments/kwmolz/akba_dod_funding_news_drop_and_jp_morgan/",
  "subreddit_subscribers": 1045085,
  "created_utc": 1610566842,
  "num_crossposts": 2,
  "media": null,
  "is_video": false,
  "original_created_utc": 1610562829,
  "the_new_excerpt": "Running up huge on volume right now! Thoughts?\n\n\n\nResearchers awarded funding to expand Akebia drug trial\n\nUTHealth News says Researchers have received funding from the Department of\nDefense to expand the Phase II clinical trial of vadadustat, a drug being\ndeveloped by Akebia that could help prevent…",
  "localize": [
    {
      "locale": "zh",
      "the_new_excerpt": "现在成交量大涨! 有什么想法？\n\n\n\n研究人员获资助扩大Akebia药物试验范围\n\nUTHealth新闻称，研究人员已经获得了来自于部的资助。\n国防部将扩大正在进行的药物vadadustat的二期临床试验。\n由Akebia开发的，可以帮助预防... ...",
      "title": "美东时间今天下午2:50，$AKBA国防部融资消息落地，摩根大通演讲。"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "現在成交量大漲! 有什麼想法？\n\n\n\n研究人員獲資助擴大Akebia藥物試驗範圍\n\nUTHealth新聞稱，研究人員已經獲得了來自於部的資助。\n國防部將擴大正在進行的藥物vadadustat的二期臨牀試驗。\n由Akebia開發的，可以幫助預防... ...",
      "title": "美東時間今天下午2:50，$AKBA國防部融資消息落地，摩根大通演講。"
    }
  ],
  "source_updated_at": 1610706383092
}